XNAS · GOSS
-3.43% · -$0.0060 · Vol 12.9M
Market closed · last close 4:00 PM ET · price as of 19:56:07 ET
Gossamer Bio, Inc. Common Stock

Gossamer Bio, Inc. Common Stock

PHARMACEUTICAL PREPARATIONS
$0.1690
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
HISTORY WINDOW BUILDING
AI Analysis
Sovereign

Why is GOSS moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Catalyst calendar
Dated receipts for GOSS are being assembled.
About Gossamer Bio, Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Listed since
2019
Employees
162
Country
US

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension).

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.1753
Day high
$0.1753
Day low
$0.1600
Previous close
$0.1750
52W high
$0.1753
-3.59% from high
52W low
$0.1600
59% of range
Market cap
$85.5M
EPS
$-0.7400
Shares out
488.8M
Volume
12.9M
VWAP
$0.1669
Price history computed in-house
SMA 50 $0.1694 · below
SMA 200 $0.1694 · below
52W position 59%
Veridion warehouse edge

Warehouse intelligence for GOSS.

Veridion Score
39
0: 921: 352: 213: 314: 665: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

GOSS insider activity

Gossamer Bio, Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for GOSS.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

GOSS contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for GOSS in this window.
Lobbying spend

GOSS lobbying filings, year to date.

Registered lobbying filings matched to Gossamer Bio, Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for GOSS in this window.
Latest news · GOSS
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for GOSS.
Options
Sovereign unlock shows live options positioning for GOSS.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.